CHINOOK THERAPEUTICS, INC.
Total Trades
64
Buys
3
Sells
33
Largest Trade
N/A
Insiders
11
Institutional Funds
2
Inst. Value
N/A
Activist Filings
15
Insider Trades
| Insider | Title | Type | Value | Shares | Price | Date |
|---|---|---|---|---|---|---|
| King Andrew James | Chief Scientific O… | EXERCISE | $1K–$15K | 5K | $0.35 | Apr 13, 2022 |
| King Andrew James | Chief Scientific O… | SELL | $15K–$50K | 3K | $13.00 | Feb 23, 2022 |
| BJERKHOLT ERIC | CFO | EXERCISE | N/A | 2K | — | Feb 15, 2022 |
| BJERKHOLT ERIC | CFO | SELL | $1K–$15K | 895 | $12.74 | Feb 15, 2022 |
| King Andrew James | Chief Scientific O… | SELL | $15K–$50K | 2K | $12.74 | Feb 15, 2022 |
| King Andrew James | Chief Scientific O… | EXERCISE | N/A | 7K | — | Feb 15, 2022 |
| Glicklich Alan | Chief Medical Offi… | EXERCISE | N/A | 6K | — | Feb 15, 2022 |
| Glicklich Alan | Chief Medical Offi… | SELL | $15K–$50K | 2K | $12.74 | Feb 15, 2022 |
| Frohlich Tom | COO | EXERCISE | N/A | 7K | — | Feb 15, 2022 |
| Frohlich Tom | COO | SELL | $15K–$50K | 4K | $12.74 | Feb 15, 2022 |
| King Andrew James | Chief Scientific O… | SELL | $15K–$50K | 3K | $13.31 | Feb 11, 2022 |
| King Andrew James | Chief Scientific O… | EXERCISE | <$1K | 3K | $0.35 | Feb 11, 2022 |
| Versant Venture Capital VII, L.P. | 10% Owner | SELL | $1M+ | 1.0M | $16.00 | Jan 5, 2022 |
| Jerel Davis | Director | SELL | $1M+ | 1.0M | $16.00 | Jan 5, 2022 |
Institutional Ownership
13F filings as of Mar 31, 2025 · 2 funds holding
| Fund | Shares | Value | Type |
|---|---|---|---|
| Farther Finance Advisors, LLC | 100 | N/A | SH |
| Parallel Advisors, LLC | 5 | N/A | SH |
Activist & 5%+ Owners
SC 13D/13G filings — investors holding 5%+ of outstanding shares
SC 13D/A · Nov 22, 2023
0.0%
0 shares
Farallon Capital Partners, L.P.
SC 13D · Aug 11, 2023
1.7%
1.2M shares
Baillie Gifford & Co (Scottish partnership)
SC 13G/A · Aug 1, 2023
2.0%
845K shares
Versant Venture Capital VII, L.P.
SC 13D/A · Mar 10, 2023
3.2%
2.1M shares
Frazier Life Sciences Public Fund, L.P.
SC 13G/A · Feb 14, 2023
4.9%
3.1M shares
SC 13G/A · Feb 14, 2023
4.7%
3.0M shares
SC 13G/A · Feb 1, 2023
6.2%
4.0M shares
Versant Venture Capital VII, L.P.
SC 13D/A · Dec 28, 2022
3.7%
2.3M shares
Versant Venture Capital VII, L.P.
SC 13D/A · Aug 22, 2022
4.6%
2.9M shares
SC 13D · Jun 1, 2022
8.4%
5.2M shares
Frazier Life Sciences Public Fund, L.P.
SC 13G · Apr 29, 2022
3.4%
1.9M shares
Versant Venture Capital VII, L.P.
SC 13D/A · Apr 13, 2022
5.3%
2.9M shares
Morningside Venture (VI) Investments Ltd.
SC 13D/A · Feb 22, 2022
0.0%
0 shares
SC 13G · Feb 16, 2022
5.0%
2.8M shares
ATP Life Science Ventures, L.P.
SC 13G/A · Jan 21, 2022
0.0%
0 shares